Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer

NCT01060514 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Lack of timely accrual.

Conditions

Metastatic Non Small Cell Lung Cancer
Metastatic Breast Cancer

Interventions

DRUG: Pazopanib
DRUG: Vinorelbine

Sponsor

Northwestern University

Collaborators

[object Object]